Psychotropics and Hepatic Issues: Nonalcoholic Fatty Liver Disease

Published: July 1, 2021, 4 p.m.

How important are ALT and AST abnormalities when prescribing psychotropics? Should you adjust dosing in patients with elevated ALT and AST? Does inflammation alter drug kinetics?

Faculty: Jonathan Meyer, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.